BEATW
Price:
$0.75
Market Cap:
$74.40M
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.[Read more]
Industry
Medical - Healthcare Information Services
IPO Date
Stock Exchange
NASDAQ
Ticker
BEATW
According to HeartBeam, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.52. This represents a change of -55.22% compared to the average of -3.39 of the last 4 quarters.
The mean historical PE Ratio of HeartBeam, Inc. over the last ten years is -91.26. The current -1.52 PE Ratio has changed 66.56% with respect to the historical average. Over the past ten years (40 quarters), BEATW's PE Ratio was at its highest in in the March 2017 quarter at 1.05K. The PE Ratio was at its lowest in in the March 2015 quarter at -863.68.
Average
-91.26
Median
-3.46
Minimum
-486.05
Maximum
49.91
Discovering the peaks and valleys of HeartBeam, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 5.03%
Maximum Annual PE Ratio = 49.91
Minimum Annual Increase = -1073.95%
Minimum Annual PE Ratio = -486.05
Year | PE Ratio | Change |
---|---|---|
2023 | -3.26 | 5.03% |
2022 | -3.11 | -14.82% |
2021 | -3.65 | -99.16% |
2020 | -436.73 | -10.15% |
2019 | -486.05 | -1073.95% |
2018 | 49.91 | -187.65% |
2017 | -56.94 | -587.61% |
2016 | 11.68 | -72.61% |
2015 | 42.64 | -257.42% |
2014 | -27.08 | -2.26% |
The current PE Ratio of HeartBeam, Inc. (BEATW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.34
5-year avg
-186.56
10-year avg
-91.26
HeartBeam, Inc.’s PE Ratio is less than BriaCell Therapeutics Corp. (-1.15), less than Biofrontera Inc. (-0.39), less than Dermata Therapeutics, Inc. (-0.16), greater than Augmedix, Inc. (-5.25), greater than Inspirato Incorporated (-1.84),
Company | PE Ratio | Market cap |
---|---|---|
-1.15 | $6.14M | |
-0.39 | $5.94M | |
-0.16 | $2.96M | |
-5.25 | $115.91M | |
-1.84 | $62.99M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HeartBeam, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like HeartBeam, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is HeartBeam, Inc.'s PE Ratio?
How is the PE Ratio calculated for HeartBeam, Inc. (BEATW)?
What is the highest PE Ratio for HeartBeam, Inc. (BEATW)?
What is the 3-year average PE Ratio for HeartBeam, Inc. (BEATW)?
What is the 5-year average PE Ratio for HeartBeam, Inc. (BEATW)?
How does the current PE Ratio for HeartBeam, Inc. (BEATW) compare to its historical average?